that VTEC are a major cause of the typical form of HUS (Karmali et al., 1985; Scotland et al., 1988) .
It appears that VTEC infection in man may be associated with a range of clinical symptoms from mild, non-bloody diarrhoea to severe manifestations such as HUS. A wide spectrum of illness may occur within a single outbreak; for example, of 34 patients who developed diarrhoea, 14 were hospitalised and 4 died (Ryan et al., 1986) . Another serious condition associated with VTEC infection is thrombotic thrombocytopenic purpura in which the clinical features of HUS are accompanied by neurological involvement and fever.
VTEC have also been implicated with disease in animals particularly calves and pigs. VTEC have been isolated from both diseased and healthy cattle but in one study there was a significant association between isolation of VTEC and diarrhoea (Mohammad et al., 1985) . VT-producing strains have also been detected in pigs with diarrhoea or oedema disease, a severe and often fatal disorder in weaned pigs (Dobrescu, 1983; Smith et al., 1983) .
Epidemiology of VTEC infections
In North America, VTEC infections associated with HC and HUS have occurred over a wide geographic area and have affected males and females of all age groups. The majority of VTEC infections are with strains belonging to serogroup 0157 and have been reported in the summer months. Outbreaks with VTEC have occurred in the community, in nursing homes for the elderly, and in daycare centres for young children, with the most severe clinical manifestations usually seen in the paediatric and geriatric populations (Ryan et al., 1986; Spika et al., 1986; Krishnan et al., 1987) .
In Britain, cases of HC and HUS associated with VTEC have been investigated during the last 5 years. An outbreak of HC occurred in the summer of 1985 in widely separated areas in East Anglia in which the epidemic strain was of serotype 0 157 : H7 (Morgan et al., in press). A prospective study of HC was conducted in England and Wales from Oct. 1985 toOct. 1986 and the cases were distributed widely throughout the country and were not noticeably related to urban or rural areas. VTEC were detected by DNA probes in 32 (39%) of 83 specimens with coliforms. Thirty of the 32 VTEC belonged to serogroup 0 1 57 confirming the importance of this serogroup as a cause of haemorrhagic colitis in areas other than North America (Smith et al., 1987a ). An outbreak of HUS associated with VTEC of serogroup 0157 occurred in the Wolverhampton area in 1983 and followed an increased incidence of HUS in the West Midlands during 1982 (Taylor et al., 1986 . The association of VTEC and HUS was further demonstrated in a study in the UK of children under 12 years. As in the HC study the patients with detectable VTEC were from many different areas of the UK (Scotland et al., 1988) .
It appears that food is the primary source of infection in man. In at least two outbreaks of HC due to E. coli of serogroup 0157, this organism has been isolated from hamburger meat (Riley et al., 1983; Ryan et al., 1986) whilst unpasteurised milk has been responsible for an outbreak of HC and two sporadic cases of HUS (Martin et al., 1986; Borczyk et al., 1987) . E. coli of serotype 0157:H7 was isolated from healthy heifers on the farms associated with the cases of HUS and the HC outbreak. Recently, it was reported that three VTproducing strains of E. coli of 0157:H7 were isolated from a calf with colibacillosis in 1977 in Argentina (0rskov et al., 1987) . This gave further support to the suggestion that cattle are a reservoir of infection by E. coli of serotype 0 1 57 : H7 in man. Examination of retail fresh meats and poultry for strains of serotype 0157:H7 showed that these organisms were present in 1.5-3-7% of samples of beef, pork, poultry and lamb (Doyle and Schoeni, 1987) .
A phage-typing scheme for VT-producing strains of E. coli of serogroup 0157 has been developed and used in epidemiological investigations of these organisms (Ahmed et al., 1987) ; 98 strains from Canada or the USA were typable and were assigned to 14 phage types. The phage-typing results of strains from outbreaks and sporadic cases correlated very closely with the epidemiological findings. This technique should prove useful in further studies of infections caused by VTEC of serogroup 0 1 57 in different parts of the world.
Methods of detecting VT and VTEC
Several methods have been employed for the detection of VTEC infection in cases of diarrhoea, HC or HUS and they fall into three categories. These are the isolation of VTEC from faecal specimens, demonstration of specific VT in faecal extracts and the presence of antibodies with VTneutralising ability in patients' sera.
The proportion of VTEC in the faecal flora may be low, often less than 1%, so that picking and testing individual colonies may not always detect the presence of VTEC. DNA probes for the VT1 and VT2 genes have been developed and with these probes used in colony-hybridisation tests, several hundred colonies from a faecal specimen can be examined, thereby increasing sensitivity (Smith et al., 1987a ; Scotland et al., 1988) .
Whereas 95% of E. coli strains are sorbitol fermenters, VTEC of serogroup 0157 do not ferment sorbitol rapidly and this test has been used to detect them (Wells et al., 1983) . Tests have used a medium containing sorbitol and an H7 antiserum (Farmer and Davis, 1985) or a sorbitol-MacConkey agar followed by agglutination with an antiserum specific for the 0157 0-antigen (March and Ratnam, 1986) . This latter technique provides a simple and useful screening method; however, it is limited because VTEC belonging to serogroups other than 0 1 57 will not be detected.
Confirmation of VT production is shown by testing strains for a cytotoxic effect on Vero cells. HeLa cells, which have been used in studies of Shiga toxin, are also susceptible to VT and several laboratories use this cell line. There have been significant differences in the methods of preparing extracts for testing of cytotoxicity. O'Brien et al. (1982) reported that, after growth under conditions of iron limitation, cell extracts of many E. coli strains produced by sonication or cell disruption had a cytotoxic effect on HeLa cells that was neutralisable by anti-Shiga toxin. In this study a few strains produced high levels of toxin equivalent to that produced by strains of S. dysenteriae of serotype 1, and in these cases cytotoxin could be detected in culture supernates as well as in cell extracts. For other strains, however, the levels of cytotoxin production were often very low and detectable in bacterial lysates only; these strains included some enteropathogenic E. coli (EPEC) and also strains from healthy persons and laboratory strains of E. coli strain K 12.
In our laboratory, filtered supernates from cultures grown in trypticase soy broth are used for testing strains for VT production (Scotland et al., 1980) . Neutralisation tests with antisera raised in rabbits against VT1 or VT2 are then performed to demonstrate production of VT1, VT2 or both toxins . Strains gave highest toxin titres after growth for between 12 h and 16 h, although there was secretion of toxin throughout exponential growth (Chart et al., 1987) . For the purpose of detecting VT there was no advantage from growing bacteria under iron restriction or limitation which resulted in poor growth and reduced yields of VT. VT was detected in culture supernates of certain EPEC strains and these strains hybridised with one or both of the VT probes. For other EPEC, which did not hybridise with either probe, VT was not detected in culture supernates although disrupted cell extracts were cytotoxic for Vero and Y 1 cells (Smith et al., 1987b; Chart et al., 1987) . This cytotoxic effect was not due to VT, which does not act on Y1 cells (Konowalchuk et al., 1977) , and any role for this non-specific activity in pathogenesis is uncertain.
The detection of VT in faecal filtrates has provided evidence of VTEC infection in several studies. A method of screening stool cultures for VT has been described (Karmali et al., 1983 (Karmali et al., , 1985 and can be modified by the use of polymyxin B to release VT from colony sweeps (Karmali, 1987) . The demonstration of VTl, VT2 or both toxins in faecal filtrates requires specific antisera for neutralisation of cytotoxicity ; production of one or both toxins was shown in faecal samples from HUS cases (Scotland et al., 1988) .
Evidence for VTEC infection has also been obtained by observing rising levels of VT-neutralising antibodies in patients' sera (Karmali et al., 1983 (Karmali et al., , 1985 .
Properties of E. coli strains producing VT
Studies of the incidence of VTEC in HC and HUS have shown that the most commonly isolated strains belong to serogroup 0157 and they possess flagellar antigen H7 or are non-motile. Neutralisation and hybridisation tests have subdivided VTEC of serogroup 0157 into three classes, strains producing VT1, or VT2, or both toxins. In all VTproducing strains of serogroup 0157 examined so far in our laboratory there has been complete agreement between results of neutralisation and hybridisation tests. One-hundred and one strains belonging to serogroup 0157 were isolated in the UK from cases of HC or HUS; only one produced VT1 alone, 68 produced VT2 and 32 strains synthesised both toxins. In neutralisation tests with strains producing VT1 and VT2 there was no neutralisation by anti-Shiga toxin or anti-VT1, whereas partial neutralisation was observed in some cases with anti-VT2. This observation suggested that in some supernates the titres of VT1 and VT2 were similar and in others VT2 titres were higher than those of VTl . Other workers have compared toxin in cell lysates and supernates and concluded that, when both toxins were produced by the same strain, VTl predominated in cell lysates and VT2 was the more active toxin in supernates (Strockbine et al., 1986) .
Adhesion of bacteria to the intestinal mucosa may be an important factor in their pathogenesis and in E. coli strains is often mediated by serologically distinct fimbrial antigens on the bacterial cell surface. Recently, Karch et al. (19873) reported that a plasmid in VT-producing strains of serogroup 0157 was necessary for the expression of fimbriae that determined the attachment of small numbers of bacteria to Intestine 407 cells grown in tissue culture. However, studies by Sherman et al.
(1 987) on the adherence of strains of serotype 0 1 57 : H7 to Intestine 407 and HEp-2 cells suggested that surface structures other than fimbriae can mediate attachment of these bacteria to epithelial cells. The plasmid, described by Karch et al. (19873) , has a mol. wt of c. 60 x lo6, and has been detected in VTEC strains of serogroup 0157 of different origins (Johnson et al., 1983; Wells et al., 1983 ; Scotland et al., 1987) . A DNA probe of 3.4 kb designated CVD419 derived from this plasmid has been evaluated for the detection of VTEC . The probe detected 106 of 107 VTEC of serogroup 0157 but hybridised with only 55 of 70 VTEC strains belonging to other serogroups.
Plasmid analysis of strains of serogroup 0157 can be used to identify strains in outbreaks and sporadic cases of infection. In addition to the plasmid that may be associated with adhesion the majority of strains in the UK producing VTl and VT2 carried a plasmid of mol. wt 4.7 x lo6 and this encoded colicin D production . Strains producing VT2 only did not have a plasmid of this size although other plasmids were sometimes present. Drug resistance in VTEC of serogroup 0 1 57 is uncommon although three drugresistant strains were identified in a survey of HC cases in England and Wales (Smith et al., 1987a) .
VTEC belonging to serogroup 0157 have some characteristic biochemical reactions that are useful for their identification. They do not ferment sorbitol within 1 day and unlike 90% of strains of E. coli they have no P-glucuronidase activity (see Krishnan et al., 1987) . It seems likely that strains of serotypes 0157:H7 or 0157:H-(i.e., non-motile) are members of one clone that has become widely distributed particularly in the last few years. There are, however, significant differences between individual strains such as the production of VT1 or VT2 or both toxins.
VT-producing strains belonging to several serogroups other than 0157 have been identified from human disease although for most serogroups the numbers are very small; a summary of such strains is shown in the table. Within these serogroups certain H types only are associated with VT production; for example, only strains of serogroup 026 with flagellar antigen 11 or that are non-motile. E. coli strains belonging to the classical enteropath- ogenic serogroups have been examined by Verocell tests and DNA hybridisation; VT production and presence of VT genes was limited to a minority of the strains (Scotland et al., 1980; Karch et al., 1987a; Smith et al., 19873) . In these studies VTEC belonging to serogroups 026, 055, 0111, 0119, 0127 and 0128 were detected. Many EPEC strains can attach closely to the microvilli of the small intestine and cause effacement of the villus tips. The adhesion of these EPEC strains can be demonstrated in vitro by their adhesion to HEp-2 cells in a "localised" manner and this property is associated with the ability to cause diarrhoea in volunteer studies (reviewed by . A few strains belonging to serogroups 055, 0111, 0 1 19 and 0127 showed HEp-2 adhesion together with VT production at a high level (Karch et al., 1987a; . VTEC of serogroups other than 0157 showed hybridisation with the VTl probe or the VT2 probe or both probes: strains hybridising with the VT2 probe alone were the most frequently isolated. It is interesting that several VTEC not belonging to serogroup 0157 were from HUS patients and only rarely from HC cases in the UK (Smith et al., 1987a; Scotland et al., 1988) . Studies in North America over a 3-year period showed that a small minority of VTEC, isolated from cases of haemorrhagic colitis, belonged to eight serogroups other than 0157 . Strains of serogroup 0128 gave heterogeneous results in the probe tests: most hybridised with both VT probes, others with the VT1 probe or the VT2 probe and one strain produced VT but did not hybridise with the probes (Smith et al., 1987b) . Further studies are required to examine the cytotoxin produced by this strain and its toxin genes.
VTEC isolated from animals belong to a large number of different serogroups Mohammad et al., 1986; Smith et al., 1988) . We have examined strains isolated in the UK or Asia from pigs and cattle with diarrhoea or from pigs with oedema disease. Vero cytotoxins and VT genes of these animal strains could be identified with antisera and DNA probes developed from VTEC of human origin . Most of the animal VTEC belonged to serogroups not usually associated with VTEC of human origin, the exceptions being strains of serogroups 05, 026, 055,0111 and 0153 that have been isolated from both human and bovine infections. However, apart from strains from serogroups 026 and 0 1 11, the human and animal strains differed in the type of VT produced. The bovine strains examined in our survey produced VT1 or VT2 but not both toxins and the levels of toxin production resembled those of strains of human origin. In contrast, the porcine strains hybridised with the VT2 probe only and in all strains cytotoxin production, neutralisable by anti-VT2, was at a low level with titres < 160. The significance of the low level of toxin production in porcine strains is unclear. The cytotoxin in culture filtrates of porcine strains was active on Vero cells but not HeLa cells and appears to be a variant of VT2 (Marques et al., 1987) .
Toxin structure, function and mode of action Both VTl and VT2 have been purified to homogeneity and, like Shiga toxin, both VTs are made up of A and B subunits (Yutsudo et al., 1987; reviewed by O'Brien and Holmes, 1987) . Based on the translated nucleotide sequences the mol. wts of the VTl A and B subunits have been calculated as c. 32 210 and 7690; both subunits are synthesised with signal peptides (Calderwood et al., 1987; Jackson et al., 19873) . The amino-acid sequence of the B subunit of Shiga toxin was identical to the deduced amino-acid sequence of VT1-B (Seidah et al., 1986) . The mol. wts of the A and B subunits of VT2, deduced from the translated nucleotide sequences, were 33 135 and 7187, respectively (Jacksonetal., 1987a ). Yutsudoetal. (1987 purified VT2 from an 0 1 57 strain and reported the mol. wts for A and B subunits as 35000 and 10700, respectively ; these values corresponded more closely to the predicted values for the unprocessed forms of the VT2 subunits. Further studies should show whether the A and B subunits of VT2 undergo proteolytic processing, like Shiga toxin and VT1, before they are incorporated into the mature holotoxin.
For both toxins the A subunit possesses the biological activity of the toxin whereas the B subunits are thought to mediate specific binding and receptor-mediated uptake of the toxin. VT 1 and VT2 have the same biological activities as Shiga toxin: cytotoxicity for Vero and HeLa cells, enterotoxicity in ligated rabbit-gut loops and mouse-paralytic lethality (O'Brien and Holmes, 1987) . The toxins can inactivate catalytically the 60s ribosomes in toxin-sensitive cells that possess a specific receptor. The receptor for VTl and VT2 has been identified and is the same as for Shiga toxin; it is a globotriosyl ceramide containing a galactose-a-( 1 + 4)-galactose-P-( 1 + 4)-glucose ceramide (Lindberg et al., 1987; Lingwood et al., 1987) .
Genetics of VT production
The genes controlling production of VT are phage-encoded in several E. coli strains. This was first demonstrated in strain H19, of serotype 026: HI 1 (Scotland et al., 1983; Smith et al., 1983) . VT phages have also been detected in strains of serogroups 0 1 11, 0 1 19, 0128 and 0157 O'Brien et al., 1984; Smith et al., 1984; Karch et al., 1987a; Willshaw et al., 1987) . VT production in porcine strains, however, does not appear to be phage mediated and the genes may be located on the chromosome Marques et al., 1987) . The VT phages could be divided into two types morphologically (figure) : those with elongated hexagonal heads and noncontractile flexible tails and those with regular hexagonal heads and shorter contractile tails  
Willshaw, H. R. Smith, S. M. Scotland, A. M. Field and B. Rowe, unpublished results). Phage particles found in strain H19 belonged to the first group whereas phages found in strains of serogroup 0 1 57 were of the second type. Strains of serogroup 026 produced VTl only whereas strains of serogroup 0157 produced VT1, VT2 or both toxins. In strains of serogroup 0157 producing both VTl and VT2, two different phages encoded VTl and VT2, respectively (Strockbine et al., 1986; . A VT1-encoding phage from strain 933, of serotype 0157:H7 (designated 9335 phage) was reported by O'Brien et al. (1984) to be virtually identical to the VT1-encoding phage from strain H19 (phage H19J) in phage morphology, restriction enzyme-digest pattern and phage polypeptides. However, studies in our laboratory showed that phages encoding VT1 or VT2 in 0157 strains, including 93 3, were morphologically indistinguis hable, similar in genome size and restriction-enzyme digests. They were clearly different in these respects from a VTl-encoding phage from strain H19, probably identical to phage H19J ; P. J. G. M. Rietra et al., unpublished results).
VT genes have been cloned in E. coli strain K12 from phages originating in strains of serogroups 026 and 0157 (Newland et al., 1985; Willshaw et al., 1985 Huang et al., 1986) . The VT1 region cloned from a strain of serogroup 0157 was very similar to the VT1 sequences cloned from strain H19 in the distribution of sites for several restriction enzymes. Comparison of these VT1 clones with a fragment encoding VT2 cloned from a phage in strain E32511 from serogroup 0157 showed there were no similarities in the presence of restrictionenzyme sites over a distance of more than 2 kb containing VT genes. In the flanking sequences of this 2-kb region, however, there were similarities between VTl and VT2 clones from two 0157 phages . Transposon mutagenesis was used to localise the VT sequences in the VT1 and VT2 clones and in this way probes for the VT genes were developed. Under "stringent" conditions for hybridisation and washing, the VT1 and VT2 probes did not cross-hybridise but under conditions of "reduced" stringency there was weak hybridisation. Thus, these results indicated that the VTl and VT2 genes were related but not closely homologous (Willshaw et al., 1985 .
The complete DNA sequences for the VTl and VT2 genes and the regulatory elements have been reported recently (Calderwood et al., 1987 ; Jackson et al., 1987a,b) . The structural genes for VT1 and VT2 shared 58% overall nucleotide-sequence homology. For both the A and B subunits of VT1 and VT2 the nucleotide and amino-acid sequence homologies varied from 55 to 60% but there were localised regions of much lower, or much greater, homology. The lowest homologies were found in the signal peptides and the carboxy ends of the A and B subunits. The organisation of the VT1 and VT2 operons was similar and the A and B subunit genes appeared to be translated independently (Jackson et al., 1987a) .
Methods for studying VTEC infections
A number of animal models, including chicks, mice, rabbits, calves and pigs, has been used to study the pathogenesis of VTEC infections. Several studies have examined strains of serotype 0 1 57 : H7 in gnotobiotic piglets Tzipori et al., 1986) . The bacteria had an attaching-andeffacing effect on microvilli similar to that seen with EPEC in animal models although, unlike EPEC, strains of serogroup 0157 proliferated in the lamina propria after destruction of the surface epithelium. The VTEC strains colonised the caecum and colon only whereas EPEC attached to the entire intestine in piglets. Gnotobiotic pigs infected with strains of serotype 0 1 57 : H7 developed lethargy, watery diarrhoea and anorexia and there was oedema of the colonic mesentery. The clinical features of these (0157) infections were similar to those observed in man except that frank blood was seen in the human faeces. Studies with gnotobiotic calves challenged with a VT-producing strain of serogroup 0 5 showed that the organisms caused attachment-and-effacement lesions in the ileum and large intestine (Moxley and Francis, 1986) .
Smith et al. (1983) examined the effect in pigs of extracts of VT-producing derivatives of E. coli strain K12. Ten of 14 pigs developed clinical signs of oedema disease and it was suggested that VT may be important in this disease. It has now been shown that porcine strains, including some from cases of oedema disease, produced VT2 or a variant of this toxin (Marques et al., 1987; Smith et al., 1988) . Purified preparations of VT1 and VT2 caused paralysis and death in mice after intraperitoneal injection (see O'Brien and Holmes, 1987) .
Recently human umbilical-cord endothelial cells have been used to study the action of VT1 (Obrig et al., 1987) . VTl had a direct and dose-dependent cytotoxic effect on these cells in culture with actively dividing cells being most sensitive. Since a characteristic renal lesion in HUS is a microangiopathy of the capillaries, the results with this model support the hypothesis that vascular endothelial cells are a primary target for VT.
Concluding remarks
This brief review shows how the knowledge of VTEC and their importance in human and animal disease has advanced very rapidly in the last 5 years. There are, however, still many unanswered questions and also a need for improvements in methods of detection of VTEC.
Comparisons of VTEC of human and animal origin have provided several interesting observations. VTEC of serogroup 0157 are clearly the most important in human disease whereas these strains have usually been isolated from healthy, rather than diseased, animals and have been detected in a range of foods, particularly raw meats. However, experiments have shown that 0157 VTEC can cause disease in a range of animal models. VTEC strains belonging to serogroups other than 0157 appear to be isolated quite frequently from cattle and pigs and there is a significant association with disease. In many cases the serogroups of these animal VTEC differ from those of VTEC associated with human disease. Some VTEC from animals may also produce heat-stable or heat-labile enterotoxins whereas, so far, VTEC of human origin have not produced enterotoxins. The production of both cytotoxin and enterotoxin may well affect the clinical symptoms observed in the animal hosts. The differences in biological activity and genetic control of VT in porcine strains compared with human and bovine strains may be important in explaining why VT production by porcine strains is much lower, in general, from that observed with other VTEC.
Further understanding of the Vero cytotoxins from different origins should result from analysis at the amino-acid or nucleotide level. This will provide information on the structure and functions of different regions of the toxin molecules. Sequence data have also produced interesting suggestions about the evolution of bacteria and Vero cytotoxins. Jackson et al. (1987a) proposed that the structural genes for VT1 and VT2 diverged from a common ancestral gene before the evolution of E. coli and S . dysenteriae serotype 1 as separate genera. Comparison of sequence data showed that the A subunit of VT1 had homology with the A subunit of ricin, a toxin from the castor-bean plant (Calderwood et al., 1987) . The two toxins share similar mechanisms of activity on eukaryotic cells and the homology may represent conservation of an active site in the two molecules. The presence of cytotoxins related to VT1 or VT2 in bacteria other than Shigella and E. coli has also been investigated (see O'Brien and Holmes, 1987) .
There is still much to learn about the precise role of VT in disease. The wide range of clinical symptoms associated with VTEC infections in man and animals suggests there are differences in the response of the host. For example, neurological disorders but not bloody diarrhoea are characteristic of oedema disease in piglets. In addition to the role of VT, the mechanisms of adhesion of VTEC in the early stages of pathogenesis are unclear at present. The association of fimbriae or other surface structures with adhesion is being investigated and will require improved in-vitro techniques as well as the use of animal models.
A variety of methods for detecting VTEC has been described but rapid, simple tests suitable for clinical laboratories are needed. Immunological techniques with ELISAs or latex-particle agglutination should provide convenient tests for these laboratories. For large-scale epidemiological surveys, the use of DNA probes may prove to be appropriate. These types of study should lead to a better understanding of the sources and vehicles of VTEC infection.
In July 1987 the first International Symposium
